ONDANSETRON
- Product NDC
- 61919-986
- 11-digit product format
- 619190986
- Labeler code
- 61919
- Product ID
- 61919-986_4d3a9354-50c1-c926-e063-6394a90ada40
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ONDANSETRON
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA090469
- Marketing category
- ANDA
- Marketing start
- 2014-01-01
- Substance
- ONDANSETRON
- Active strength
- 8 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ONDANSETRON
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4AF302ESOS |
| Rxcui | 312087 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-986-10 | ONDANSETRON | 10 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 10 | | 6 |
| 61919-986-30 | ONDANSETRON | 30 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 30 | | 6 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ONDANSETRON | ACTIVE INGREDIENT | 4AF302ESOS | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| ONDANSETRON | ACTIVE MOIETY | 4AF302ESOS | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-986 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [DIRECT RX] | 5 | Current NDC, Legacy NDC, 2 package rows | 20230113_b38feff2-900a-4e0c-8260-8f090edbc0bc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-986-10 | 61919098610 | 10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (61919-986-10) | 2014-01-01 | 0000-00-00 | No | No | Current |
| 61919-986-30 | 61919098630 | 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON (61919-986-30) | 2014-01-01 | 0000-00-00 | No | No | Current |